Select a Test
Select a Product
Your Shopping Cart
Contains 0 Items ($0.00)
Bookmark and Share


Search Products

Search Manufacturer
Newsletter Signup
* indicates required field
Contact Information
Please send correspondence to the following address:

Office Address:
Integrative Psychiatry
3392 Magic Oak Lane
Sarasota FL 34232

Phone Numbers:
Toll Free:(800) 385-7863
Fax:(941) 371-7667

E-mail: Contact Form

internet phone service

Viewing: Metametrix Estronex 2/16 OH Estrogen Ratio

Product Name: Metametrix Estronex 2/16 OH Estrogen Ratio

Description:
Metametrix Estronex 2/16 OH Estrogen Ratio helps women to determine their risk for breast cancer. The Estronex 2/16 Test from Metametrix Clinical Laboratory measures the ratio of these two critical estrogen metabolites from a single urine specimen. Estronex 2/16 ratios less than 2.0 indicate increasing long-term risk for breast, cervical, and other estrogen-sensitive cancers. Importantly, nutritional interventions can help raise Estronex 2/16 ratios and decrease long-term risk. The Estronex 2/16 Test features: A simple first-morning urine specimen; no blood draw is necessary. Economical, so you can retest often to monitor therapy. Bone Resorption Test can be added for osteoporosis risk assessment at only a small incremental cost. Doctors order provided, you receive the results.

OptionsQuantity:

To See A Sample Report Click Here!

When a major study of hormone replacement therapy in women was recently discontinued, clinicians and patients alike were left with unanswered questions. Why are certain tissues, such as the breast, susceptible to estrogen-induced cancer? Why are some women susceptible, but not others? Researchers at Rockefeller University have found that the body metabolizes estrogens into several different metabolites that can impact cancer development.



Back to the top

Featured Products

Click
Powered By CMATION® Content Management System
Largo Florida Web Design & Hosting by Little Frog Innovations